# ST266 in UV-induced Inflammation

> **NCT02389777** · PHASE2 · COMPLETED · sponsor: **Noveome Biotherapeutics, formerly Stemnion** · enrollment: 10 (actual)

## Conditions studied

- Skin Burns

## Interventions

- **BIOLOGICAL:** ST266 immediate
- **BIOLOGICAL:** ST266 delayed

## Key facts

- **NCT ID:** NCT02389777
- **Lead sponsor:** Noveome Biotherapeutics, formerly Stemnion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389777, "ST266 in UV-induced Inflammation". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02389777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*